|
Peptide Name |
CAT# |
Peptide Sequence |
|
HBV Seq1 aa: 141-151 |
1972-2-1 |
Ser-Thr-Leu-Pro-Glu-Thr-Thr-Val-Val-Arg-Arg |
|
HBV Seq1 aa: 18-27 |
1972-2-2 |
Phe-Leu-Pro-Ser-Asp-Phe-Phe-Pro-Ser-Val |
|
HBV Seq1 aa: 63-71 |
1972-2-3 |
Gly-Glu-Leu-Met-Thr-Leu-Ala-Thr-Trp |
|
HBV Seq1 aa: 93-100 |
1972-2-4 |
Met-Gly-Leu-Lys-Ile-Arg-Gln-Leu |
|
HBV Seq2 aa: 179-186 |
1972-2-5 |
Phe-Val-Gln-Trp-Phe-Val-Gly-Leu |
|
HBV Seq2 aa: 208-216 |
1972-2-6 |
Ile-Val-Ser-Pro-Phe-Ile-Pro-Leu-Leu |
|
HBV Seq2 aa: 208-216 |
1972-2-7 |
Ile-Leu-Ser-Pro-Phe-Leu-Pro-Leu-Leu |
|
HBV Seq2 aa: 28-39 |
1972-2-8 |
Ile-Pro-Gln-Ser-Leu-Asp-Ser-Trp-Trp-Thr-Ser-Leu |
|
Hepatitis B Virus Pre-S Region (120-145) |
1972-2-9 |
Met-Gln-Trp-Asn-Ser-Thr-Thr-Phe-His-Gln-Thr-Leu-Gln-Asp-Pro-Arg-Val-Arg-Gly-Leu-Tyr-Phe-Pro-Ala-Gly-Gly |
|
Hepatitis B Virus Receptor Binding Fragment |
1972-2-10 |
Pro-Leu-Gly-Phe-Phe-Pro-Asp-His-Gln-Leu-Asp-Pro-Ala-Phe-Gly-Ala-Asn-Ser-Asn-Asn-Pro-Asp-Trp-Asp-Phe-Asn-Pro |
|
[Ala127] Hepatitis B Virus Pre-S Region (120-131) |
1972-2-11 |
Met-Gln-Trp-Asn-Ser-Thr-Ala-Phe-His-Gln-Thr |
|
Ac-Asp-DGla-Leu-Ile-b-cyclohexyl-Ala-Cys |
1972-2-12 |
Ac-Asp-DGla-Leu-Ile-Cha-Cys |
|
Ac-Glu-Glu-Val-Val-Ala-Cys-AMC |
1972-2-13 |
Ac-Glu-Glu-Val-Val-Ala-Cys-AMC |
|
Ac-Glu-Glu-Val-Val-Ala-Cys-pNA |
1972-2-14 |
Ac-Glu-Glu-Val-Val-Ala-Cys-pNA |
|
Glu-Ala-Gly-Asp-Asp-Ile-Val-Pro-Cys-Ser-Met-Ser-Tyr-Thr-Trp-Thr-Gly-Ala |
1972-2-15 |
Glu-Ala-Gly-Asp-Asp-Ile-Val-Pro-Cys-Ser-Met-Ser-Tyr-Thr-Trp-Thr-Gly-Ala |
|
HCV Core Protein (107-114) |
1972-2-16 |
Trp-Gly-Pro-Asn-Asp-Pro-Arg-Arg |
|
HCV Core Protein (19-25) |
1972-2-17 |
Pro-Gln-Asp-Val-Lys-Phe-Pro |
|
HCV Core Protein (59-68) |
1972-2-18 |
Arg-Gly-Arg-Arg-Gln-Pro-Ile-Pro-Lys-Ala |
|
HCV NS4A Protein (18-40) (JT strain) |
1972-2-19 |
Leu-Thr-Thr-Gly-Ser-Val-Val-Ile-Val-Gly-Arg-Ile-Ile-Leu-Ser-Gly-Arg-Pro-Ala-Val-Val-Pro-Asp |
|
HCV NS4A Protein (21-34) (JT strain) |
1972-2-20 |
Gly-Ser-Val-Val-Ile-Val-Gly-Arg-Ile-Ile-Leu-Ser-Gly-Arg |
|
HCV Peptide Aa: 257-266 |
1972-2-21 |
Thr-Ile-Arg-Arg-His-Val-Asp-Leu-Leu-Val |
|
HCV Peptide Aa: 35-44 |
1972-2-22 |
Tyr-Leu-Leu-Pro-Arg-Arg-Gly-Pro-Arg-Leu |
|
HCV Peptide Aa:131-140 |
1972-2-23 |
Ala-Asp-Leu-Met-Gly-Tyr-Ile-Pro-Leu-Val |
|
HCV-1 e2 Protein (484-499) |
1972-2-24 |
Pro-Tyr-Cys-Trp-His-Tyr-Pro-Pro-Lys-Pro-Cys-Gly-Ile-Val-Pro-Ala |
|
HCV-1 e2 Protein (554-569) |
1972-2-25 |
Trp-Met-Asn-Ser-Thr-Gly-Phe-Thr-Lys-Val-Cys-Gly-Ala-Pro-Pro-Cys |
|
Lys(biotinyl)-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-Tyr-Lys-Lys-NH2 |
1972-2-26 |
Lys(biotinyl)-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-Tyr-Lys-Lys-NH2 |
|
Lys-Lys-Glu-Asp-Val-Val-Abu-Cys |
1972-2-27 |
Lys-Lys-Glu-Asp-Val-Val-Abu-Cys |
|
Lys-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-Tyr-Lys-Lys-NH2 |
1972-2-28 |
Lys-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-Tyr-Lys-Lys-NH2 |
|
Mca-Glu-Asp-Ala-Ser-Thr-Pro-Cys-OH |
1972-2-29 |
Mca-Glu-Asp-Ala-Ser-Thr-Pro-Cys |
|
Mca-Glu-Asp-Ala-Ser-Thr-Pro-Cys-Ser-Gly-Ser-p-nitro-Phe-Leu |
1972-3-1 |
Mca-Glu-Asp-Ala-Ser-Thr-Pro-Cys-Ser-Gly-Ser-(NO2)Phe-Leu |
|
Mca-Lys-Lys-Glu-Asp-Val-Val-Abu-Cys |
1972-3-2 |
Mca-Lys-Lys-Glu-Asp-Val-Val-Abu-Cys |
|
Mca-Lys-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-p-nitro-Phe-Lys-Lys-NH2 |
1972-3-3 |
Mca-Lys-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-(NO2)Phe-Lys-Lys-NH2 |
|
Ser-Abu-Ser-Tyr-Lys-Lys-NH2 |
1972-3-4 |
Ser-Abu-Ser-Tyr-Lys-Lys-NH2 |
|
Ser-Gly-Ser-p-nitro-Phe-Leu |
1972-3-5 |
Ser-Gly-Ser-(NO2)Phe-Leu |
|
2F5 epitope |
1972-3-6 |
Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn |
|
Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 |
1972-3-7 |
Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 |
|
Alloferon 1 |
1972-3-8 |
His-Gly-Val-Ser-Gly-His-Gly-Gln-His-Gly-Val-His-Gly |
|
Alloferon 2 |
1972-3-9 |
Gly-Val-Ser-Gly-His-Gly-Gln-His-Gly-Val-His-Gly |
|
DABCYL-y-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS |
1972-3-10 |
4-(4-Dimethylaminophenylazo)benzoyl-γ-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-5-[(2-aminoethyl)amino]-naphthalene-1-sulfonic acid |
|
ELDKWA |
1972-3-11 |
Glu-Leu-Asp-Lys-Trp-Ala |
|
Herpes Virus Inhibitor 1 |
1972-3-12 |
Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu |
|
Herpes Virus Inhibitor 2 |
1972-3-13 |
Tyr-Gly-Ala-Val-Val-Asn-Asp-Leu |
|
HIV (gp120) (318-327) |
1972-3-14 |
Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile |
|
HIV Envelope Protein (254-274) |
1972-3-15 |
Cys-Thr-His-Gly-Ile-Arg-Pro-Val-Val-Ser-Thr-Gln-Leu-Leu-Leu-Asn-Gly-Ser-Leu-Ala-Glu |
|
HIV Gag (129-135 ) |
1972-3-16 |
Ser-Glu-Asn-Tyr-Pro-Ile-Val |
|
HIV Substrate |
1972-3-17 |
Lys-Ala-Arg-Val-Nle-Phe(NO2)-Glu-Ala-Nle-NH2 |
|
Peptide T |
1972-3-18 |
Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr |
|
R15K, HIV-1 Inhibitory Peptide |
1972-3-19 |
Arg-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile-Gly-Lys |
|
[3,5 Diiodo-Tyr7] Peptide T |
1972-3-20 |
Ala-Ser-Thr-Thr-Thr-Asn-(3,5 diiodo)Tyr-Thr |
|
[Cys(Bzl)84] CD (81-92) |
1972-3-21 |
Thr-Tyr-Ile-Cys(benzyl)-Glu-Val-Glu-Asp-Gln-Lys-Glu-Glu |
|
[DAla1] Peptide T, amide |
1972-3-22 |
DAla-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2 |
|
gp120, HIV-1 MN |
1972-3-23 |
Tyr-Asn-Ala-Lys-Arg-Lys-Arg-Ile-His-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Tyr-Thr-Thr-Lys-Asn-Ile-Ile |
|
gp38 |
1972-3-24 |
Arg-Val-Thr-Ala-Ile-Glu-Lys-Tyr-Leu-Gln-Asp-Gln-Ala-Arg-Leu-Asn-Ser-Trp-Gly-Cys-Ala-Phe-Arg-Gln-Val-Cys |
|
HA Peptide |
1972-3-25 |
Tyr-Pro-Tyr-Asp-Val-Pro-Asp-Tyr-Ala |
|
HIV-1, HIV-2 Protease Substrate |
1972-3-26 |
Ala-Thr-Leu-Asn-Phe-Pro-Ile-Ser-Pro-Trp |
|
Lactalbumin B (50-53) Alpha [Lactorphin Alpha], bovine |
1972-3-27 |
Tyr-Gly-Leu-Phe |
|
VSV-G Peptide |
1972-3-28 |
Tyr-Thr-Asp-Ile-Glu-Met-Asn-Arg-Leu-Gly-Lys |
